Pathogenesis of tuberculosis refer just robins

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

I now have all the information needed. Let me compile a comprehensive answer from Robbins.

Pathogenesis of Tuberculosis

Source: Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease

Causative Organism and Transmission

Tuberculosis (TB) is a communicable chronic granulomatous disease caused by Mycobacterium tuberculosis. It most often affects the lungs but can involve any organ. Transmission is primarily by airborne droplets from an individual with active disease. The source of M. bovis infection (historically via contaminated milk) is now rare in countries with pasteurized milk.

Key Concept: Infection vs. Disease

Infection implies seeding of a tissue focus, which may or may not progress to disease. Most newly infected, immunocompetent individuals develop an asymptomatic, self-limited focus that heals as a tiny fibro-calcific nodule. Viable organisms remain dormant for decades. If immune defenses are lowered, reactivation can produce communicable, life-threatening disease.

Pathogenesis - Step by Step

The course of TB is dictated by the development of cell-mediated (Th1) immunity, which both confers resistance and causes tissue hypersensitivity and damage. The effector cells for protective immunity and damaging hypersensitivity are the same - so the appearance of tissue hypersensitivity also signals acquisition of immunity.

Phase A: Before Activation of Cell-Mediated Immunity (First ~3 Weeks)

Sequence of events in primary pulmonary tuberculosis - Phase A: infection before activation of cell-mediated immunity

1. Entry into Macrophages

M. tuberculosis is inhaled and reaches alveoli
It enters alveolar macrophages by phagocytosis mediated by several receptors:
- Mannose receptor (recognizes mannose-capped lipoarabinomannan on the mycobacterial wall)
- Complement receptor CR3 (Mac-1/CD11b/CD18) - binds C3b-opsonized bacteria
- Other pattern-recognition receptors (TLRs)

2. Replication Within Macrophages (Phagosome Escape)

Once phagocytosed, M. tuberculosis inhibits phagosome maturation and blocks phagolysosome fusion
Mechanism: The bacterium recruits a host protein called coronin to the phagosome membrane, which activates the phosphatase calcineurin, leading to inhibition of phagosome-lysosome fusion
Result: No acidification, no reactive nitrogen/oxygen species - bacteria replicate unchecked within the phagosome
Bacteria also infect neutrophils, resist killing, induce death of infected cells

3. Unchecked Bacillary Proliferation and Bacteremia

During the first 3 weeks, bacilli proliferate freely in pulmonary alveolar macrophages and air spaces
This results in bacteremia and seeding of multiple sites (lymph nodes, liver, spleen, bone marrow, kidneys, meninges, etc.)
Most individuals are asymptomatic or have a mild flu-like illness at this stage

Phase B: Initiation and Consequences of T Cell-Mediated Immunity (~3 Weeks Onward)

4. Development of Cell-Mediated Immunity

Dendritic cells migrate from lungs to draining lymph nodes, displaying mycobacterial antigens via Class II MHC to CD4+ T cells
IL-12 (and IL-18) secreted by antigen-presenting cells drive differentiation of CD4+ Th1 cells
TLR2 stimulation by mycobacterial ligands promotes IL-12 production

5. Th1-Mediated Macrophage Activation

Th1 cells produce IFN-γ, the critical mediator that activates macrophages
IFN-γ activates macrophages via three mechanisms:
1. iNOS upregulation → produces nitric oxide (NO) and reactive nitrogen intermediates → kills mycobacteria in the acidic phagolysosome
2. Antimicrobial peptides (defensins/cathelicidins) are mobilized against bacteria
3. Autophagy is stimulated → sequesters and destroys intracellular bacteria
TNF is also released → responsible for recruitment of monocytes → these develop into activated macrophages that form granulomas

6. Granulomatous Inflammation and Tissue Damage

Macrophages activated by IFN-γ differentiate into "epithelioid histiocytes"
These aggregate to form granulomas; some fuse to form Langhans giant cells
TNF and chemokines recruit more monocytes
In many individuals, this response halts infection before significant tissue destruction
In others (due to age, immunosuppression), ongoing immune response results in caseous necrosis - sometimes without granuloma formation

7. Caseous Necrosis

The central area of granulomas undergoes caseous (cheese-like) necrosis due to:
- Delayed-type hypersensitivity reaction
- Cytotoxic T cell (CD8+) killing of infected macrophages
Important: The necrotic material is relatively inhospitable to bacterial growth, but viable bacilli can persist

8. Tuberculin Positivity (Delayed Hypersensitivity)

The development of Th1 immunity is detected by the tuberculin (PPD/Mantoux) skin test or IFN-γ release assays (IGRAs)
A positive test = T cell-mediated immunity to mycobacterial antigens
Loss of tuberculin positivity (anergy) in a known TB-infected patient is an ominous sign of fading resistance and heralds severe disease

Summary Diagram

Stage	Timing	Key Events
Entry	Day 0	Inhaled bacilli phagocytosed by alveolar macrophages via mannose receptor & CR3
Phagosome escape	Days 1-3	Coronin-calcineurin pathway blocks phagolysosome fusion; unchecked replication
Bacteremia	Week 1-3	Bacilli spread to hilar nodes and hematogenous seeding of multiple organs
CMI onset	~Week 3	Dendritic cells activate CD4+ T cells in lymph nodes; IL-12 drives Th1 differentiation
Macrophage activation	Week 3+	IFN-γ → iNOS → NO; defensins; autophagy → mycobacterial killing
Granuloma formation	Week 3+	Epithelioid histiocytes + Langhans giants + caseous necrosis → wall off infection
Containment (95%)	Weeks-months	Ghon focus calcifies; latent infection established
Failure (5%)	Variable	Progressive primary or later reactivation disease

Critical Mediators

Mediator	Source	Role
IL-12	Macrophages, DCs	Drives Th1 differentiation
IFN-γ	Th1 cells	Activates macrophages; most critical mediator
TNF	Activated macrophages	Monocyte recruitment; granuloma maintenance
NO (via iNOS)	Activated macrophages	Key bactericidal molecule
Defensins/cathelicidin	Macrophages	Direct antimycobacterial toxicity

Defects in any component of this Th1 pathway (IL-12, IFN-γ, TNF, or NO production) result in poorly formed granulomas, absent resistance, and progressive disease.

Primary Tuberculosis

Develops in a previously unexposed, unsensitized individual
Only ~5% of newly infected people develop significant disease
Ghon focus: 1-1.5 cm gray-white area of caseous consolidation, typically in the lower upper lobe or upper lower lobe, close to the pleura
Ghon complex: Ghon focus + ipsilateral hilar/mediastinal lymph node caseation (connected by lymphangitis)

Gross pathology - Ghon Complex (Robbins, Cotran & Kumar):

Primary pulmonary tuberculosis, Ghon complex. Gray-white parenchymal focus (red arrow) under pleura in lower upper lobe; hilar lymph nodes with caseation (blue arrow)

In ~95% of cases, cell-mediated immunity controls infection → Ghon complex undergoes progressive fibrosis and calcification (Ranke complex)
Hematogenous seeding occurs in all primary infections, but is controlled by immunity

Progressive primary TB occurs in:

Overtly immunocompromised patients
Severe malnutrition
HIV-positive with CD4+ T cells <200 cells/μL (granulomatous reaction may be absent)

Secondary (Reactivation) Tuberculosis

Arises in a previously sensitized host - from reactivation of dormant primary lesions (decades later) or reinfection
Only <5% of patients with primary TB develop secondary TB

Key features distinguishing from primary TB:

Feature	Primary TB	Secondary TB
Host	Unsensitized	Previously sensitized
Location	Lower upper lobe / upper lower lobe (subpleural)	Apex of upper lobes (both lungs)
Lymph node involvement	Prominent (hilar caseation)	Less prominent
Cavitation	Rare	Common - important source of infectivity
Bacteremia/seeding	Common	Less common (walled off rapidly)

Apical location in secondary TB is thought to relate to high oxygen tension at the apices (favorable for M. tuberculosis)
Because of pre-existing hypersensitivity, bacilli elicit a prompt tissue response that walls off the focus
Cavitation occurs when caseous material liquefies and drains into bronchi → patients produce infectious sputum

In HIV patients:

Mildly immunocompromised (CD4+ >300): "usual" secondary TB with apical cavitation
Severely immunocompromised (CD4+ <200): resembles progressive primary TB (lower/middle lobe consolidation, hilar adenopathy, no cavitation); extrapulmonary involvement >50%

Why TNF Matters Clinically

Patients with rheumatoid arthritis or IBD treated with TNF antagonists are at markedly increased risk for TB reactivation, because TNF is essential for maintaining granuloma integrity and monocyte recruitment.

Robbins & Kumar Basic Pathology (9780323790185), p. 475-477; Robbins, Cotran & Kumar Pathologic Basis of Disease (9780443264528), p. 351-354

This is a shared conversation. Sign in to Orris to start your own chat.